Barbara J McClure

13PUBLICATIONS
24CO-AUTHORS
Medical mycologyPredictive and prognostic markersHaematological tumoursBiologically active moleculesCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 15, 2026
Advances in Modeling Multiple Myeloma Within the Bone Marrow Tumor Microenvironment for Exploration of Current and Emerging Therapies.

|May 18, 2026
Elevated desmoglein-2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high-risk cytogenetics and a distinct gene expression profile.

|Aug 28, 2025
High Expression of NTRK1 in ETV6::RUNX1 Positive Acute Lymphoblastic Leukaemia Drives Factor Independence and Sensitivity to Larotrectinib.

Luke Quinlan, Elyse C Page, Jacqueline Rehn

|Jun 07, 2024
Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy.

Laura N Eadie, Elias Lagonik, Elyse C Page

|Mar 22, 2024
The 10th Barossa meeting: Cell Signalling to Cancer Medicine.

Winnie L Kan, Barbara J McClure, Christopher N Hahn

|Oct 14, 2023
Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients.

Ashlee J Thomson, Jacqueline A Rehn, Susan L Heatley

Pageof 3

Frequent Collaborators

8 joint publications

Deborah L White

6 joint publications

Susan L Heatley

4 joint publications

Laura N Eadie

4 joint publications

Charlotte E J Toomes